Matsuda Masaru

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$18,542.64
Insider Sells Quantity
11
Insider Sells Sum
$316,780.88

Insider Activity of Matsuda Masaru

According to the SEC Form 4 filings, Matsuda Masaru, being in a position of

  1. See Remarks at Arcutis Biotherapeutics, Inc.,
    оver the last 12 months, has bought 5657 shares for $18,543, and sold 22561 share for $209,438,
    over all time since 2022-05-27, has bought 5657 shares for $18,543, and sold 31190 shares for $316,781.

The largest purchase of all time was on 2024-11-30 and amounted to 1657 shares of Arcutis Biotherapeutics, Inc. for $11,775.

The largest sale of all time was on 2024-08-02 and amounted to 5220 shares of Arcutis Biotherapeutics, Inc. for $47,064.

Biography of Matsuda Masaru

No biography is available at this moment.

2024-11-30PurchaseArcutis Biotherapeutics, Inc.
ARQT
See Remarks
1,657
0.0008%
$7.11$11,7750%
2024-11-19SaleArcutis Biotherapeutics, Inc.
ARQT
See Remarks
1,775
0.0015%
$9.68$17,190+4.7%
2024-11-04SaleArcutis Biotherapeutics, Inc.
ARQT
See Remarks
5,015
0.0042%
$8.68$43,551+40.48%
2024-08-02SaleArcutis Biotherapeutics, Inc.
ARQT
See Remarks
5,220
0.0044%
$9.02$47,064+10.05%
2024-05-31PurchaseArcutis Biotherapeutics, Inc.
ARQT
See Remarks
4,000
0.0007%
$1.69$6,768+17.03%
2024-05-28SaleArcutis Biotherapeutics, Inc.
ARQT
See Remark
1,775
0.0016%
$9.01$15,988+10.25%
2024-05-02SaleArcutis Biotherapeutics, Inc.
ARQT
See Remark
5,016
0.0044%
$8.74$43,829+12.44%
2024-03-04SaleArcutis Biotherapeutics, Inc.
ARQT
See Remark
3,760
0.004%
$11.12$41,816-11.14%
2023-11-21SaleArcutis Biotherapeutics, Inc.
ARQT
See Remark
1,850
0.0021%
$1.98$3,661+381.48%
2023-05-31SaleArcutis Biotherapeutics, Inc.
ARQT
See Remark
1,830
0.0031%
$7.80$14,278+6.79%
2023-03-02SaleArcutis Biotherapeutics, Inc.
ARQT
See Remarks
1,434
0.0023%
$15.83$22,696-48.14%
2022-11-21SaleArcutis Biotherapeutics, Inc.
ARQT
See Remark
1,720
0.0031%
$18.19$31,289-42.97%
2022-05-27SaleArcutis Biotherapeutics, Inc.
ARQT
SVP and General Counsel
1,795
0.0033%
$19.73$35,419-17.89%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.